FDA Inspection 1195349 — David P. Walling, Ph.D.
The FDA completed an inspection of David P. Walling, Ph.D. on January 13, 2023 in Garden Grove, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 13, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Garden Grove, CA (United States)
Additional Details
Clinical BA/BE